The Medical Letter on Drugs and Therapeutics
August 6, 2012
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
August 6, 2012 (Issue: 1396)Three recent publications have focused attention once more on the contentious question of whether men should be screened for prostate cancer by measuring serum concentrations of prostate specific antigen (PSA).
1. VA Moyer et al. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 157:120.
2. WJ Catalona et al. What the US Preventive Services Task Force missed in its prostate cancer screening recommendation. Ann Intern Med 2012; 157:137.
3. TJ Wilt et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012; 367:203.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.